Skip to main content

Back to guidelines homepage

Long-acting reversible contraception (update) (NICE clinical guideline 30)

Published: 01/09/2014

This guideline was produced by the National Collaborating Centre for Women’s and Children’s Health (NCC-WCH) on behalf of the National Institute of Health and Care Excellence (NICE).

It covers specific issues for the use of these methods during the menarche and before the menopause, and by particular groups, including women who have HIV, learning disabilities or physical disabilities, or are younger than 16 years.

The addendum to NICE clinical guideline 30 updates the recommendations on progestogen-only subdermal implants in section 1.5 of the guideline. The addendum also contains details of the methods and evidence used to update these recommendations. The progestogen-only subdermal implant Implanon, previously recommended in this guideline, is no longer available and has been replaced by Nexplanon. Nexplanon contains the same amount of the same drug as Implanon, but the summaries of product characteristics for the two devices are not identical.